Sign up to save your podcasts
Or
Share Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators
Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the potential role of CELMoDs in the management of multiple myeloma, supporting clinical data and ongoing investigations.
CME information and select publications here.
View all episodes
By Dr. Neil Love
4.4
7272 ratings
Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the potential role of CELMoDs in the management of multiple myeloma, supporting clinical data and ongoing investigations.
CME information and select publications here.
More shows like Hematologic Oncology Update
View all
NEJM This Week
318 Listeners
Journal of Clinical Oncology (JCO) Podcast
40 Listeners
Breast Cancer Update
66 Listeners
Lung Cancer Update
31 Listeners
Prostate Cancer Update
13 Listeners
Gastrointestinal Cancer Update
17 Listeners
Gynecologic Oncology Update
12 Listeners
Dermatologic Oncology Update
0 Listeners
Research To Practice | Oncology Videos
121 Listeners
ASCO Daily News
58 Listeners
Core IM | Internal Medicine Podcast
1,141 Listeners
ASCO Guidelines
47 Listeners
VJHemOnc Podcast
2 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Blood Podcast
53 Listeners
Oncology Today with Dr Neil Love
61 Listeners
Blood Cancer Talks
51 Listeners
Two Onc Docs
196 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
47 Listeners
WolverHeme Happy Hour
30 Listeners
Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing
0 Listeners